Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Growth is said to be driven by the deeper penetration of biosimilars in developed and emerging markets as a result of clearer regulatory pathways.

Biosimilars and Follow-on-Biologics Market to Hit $35 Billion Globally by 2020

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

In a new draft guidance, FDA proposes the use of a nonproprietary name plus a four-letter suffix to identify all biologic products, both new and old.

FDA Releases Guidance on Biosimilar Nomenclature, Requests Comments on Interchangeable Product Naming

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Andrew Bulpin, executive vice president of EMD Millipore’s Process Solutions Business, speaks to Pharmaceutical Technology about the trends shaping the biopharmaceutical manufacturing industry.

Cell Culture, Single Use, and the Evolving Biopharmaceutical Landscape

Randy Wald, senior research fellow at Bend Research, part of Capsugel Dosage Form Solutions shares insights on trends shaping the evolving solid dosage manufacturing landscape, including advances in excipients and the impact on formulation development and manufacturing processes.

Key Considerations in Excipients Selection for Solid Dosage Forms

Elizabeth Scheu & Kniss will supply replacement parts for Bosch capsule filling machines.

Elizabeth Scheu & Kniss Partners with Carlisle Precision Machining to Supply Capsule-Filling Machine Replacement Parts

The company adds a few new arguments-as well as new stakeholder support-to its Citizen Petition on biosimilar naming.

AbbVie Amends its Citizen Petition to FDA

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

The complex task of stabilizing proteins is made more challenging due to the limited number of approved excipients.

Excipient Selection for Protein Stabilization

WuXi PharmaTech and TruTag Technologies successfully applied and detected TruTag's edible microtags on solid-dosage drug products and found no effect on dissolution.

WuXi PharmaTech and TruTag Technologies Complete Successful Testing of On-Dose Authentication Solution

CMC Biologics will manufacture monoclonal antibodies (mAbs) and provide process development services for the PATH Malaria Vaccine Initiative.

CMC Biologics to Manufacture mAbs for the Treatment of Malaria

GEA's self-contained homogenizer is designed for laboratory applications, including cell dispersions.